Contracts Finder · Planning
Specialised - Human Cell Line Recombinant Factor VIII
A public procurement published by NHS ENGLAND via Contracts Finder.
Contracts FinderPlanning
- —
- Award value
- £15m
- Tender value
- 0
- Suppliers
- 0
- Awards
- 9
- Notices
- Planning
- Stage
Overview
NHS National Framework Agreement for Human Cell Line Recombinant Factor VIII
Key details
- Buyer
- NHS ENGLAND
- Source
- Contracts Finder
- Lifecycle stage
- Planning
- Status
- planned
- CPV classification
- 33141510 — Blood products
- Currency
- GBP
- Total award value
- —
- Tender value
- £15,000,000
- First published
- 1 Feb 2018
- Last updated
- 4 Nov 2019
Notice timeline
Every published notice in this procurement's lifecycle.
- Planning noticeSpecialised - Human Cell Line Recombinant Factor VIII
- Planning noticeSpecialised - Human Cell Line Recombinant Factor VIII
- Planning noticeSpecialised - Human Cell Line Recombinant Factor VIII
- Planning noticeSpecialised - Human Cell Line Recombinant Factor VIII
- Planning noticeSpecialised - Human Cell Line Recombinant Factor VIII
- Planning noticeSpecialised - Human Cell Line Recombinant Factor VIII
- Planning noticeSpecialised - Human Cell Line Recombinant Factor VIII
- Planning noticeSpecialised - Human Cell Line Recombinant Factor VIII
- Planning noticeSpecialised - Human Cell Line Recombinant Factor VIII
Frameworks & programmes
More from NHS ENGLAND
Products for the treatment of Haemophilia A
Planning · Contracts FinderNHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care
Planning · Contracts FinderNHS Framework Agreement for the supply of products for the teratment of Haemophilia A
Planning · Contracts FinderNHS National Framework Agreement for the supply of Haemophilia A
Planning · Contracts FinderAdult Influenza Vaccines - Secondary Care
Planning · Contracts FinderNHS Framework Agreement for the Supply of Human Normal Immunoglobulin & Anti-D Immunoglobulin
Planning · Contracts FinderFAQs about this procurement
Who is the buyer for "Specialised - Human Cell Line Recombinant Factor VIII"?
Specialised - Human Cell Line Recombinant Factor VIII is a UK public-sector procurement published by NHS ENGLAND via Contracts Finder.
Has "Specialised - Human Cell Line Recombinant Factor VIII" been awarded?
No award has been recorded yet. The current lifecycle stage is "Planning".
What is "Specialised - Human Cell Line Recombinant Factor VIII" worth?
The reported tender value is £15,000,000.
When was "Specialised - Human Cell Line Recombinant Factor VIII" published?
It was first published on 1 Feb 2018 and last updated on 4 Nov 2019, across 9 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable